RadNet, Inc.

Healthcare · Medical - Diagnostics & Research

Overall research band Weak

Quality Very weak

Valuation Very weak

Balance sheet Very weak

Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

RadNet, Inc. is a healthcare services company specializing in outpatient diagnostic imaging across the United States. The company provides a wide range of advanced imaging services, including MRI, CT, PET, nuclear medicine, mammography, ultrasound, and general diagnostic radiology, as well as specialized procedures. RadNet also develops and markets computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and related support. Additionally, the company integrates artificial intelligence solutions to assist radiologists, particularly in mammography and cancer diagnostics. RadNet serves patients and healthcare providers through its network of 347 centers in seven states, generating revenue primarily from imaging services and technology solutions.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC2.5%Model input; read with the evidence status and period context.

Operating margin3.8%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years11.6%Model input; read with the evidence status and period context.

FCF margin-6.9%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.